u/kalabharath

$NAGE CEO spent the earnings call seeding a takeout narrative. 4 buyer universes:

🛒 CPG (Thorne/$PG $3.8B comp) → $NSRGY (Nestlé Health Science), $PG

💄 Beauty ("2 global skincare cos") → $LRLCY (L'Oréal)

💊 Pharma (Reata/$BIIB $7.3B comp) → $BIIB, for NB4168

📱 Telehealth → $HIMS

But: comp gated on $15 PSUs, so he's incentivized to talk his book. "In discussions" ≠ deal. No name, no LOI, no timeline. Real tell = a signed exclusive skincare supply deal w/ a named $LRLCY-tier buyer. Until then it's CEO optionality, not a catalyst